Pennsylvania And Weybridge

ViroPharma Incorporated and Idis Partner to Facilitate International Access to Certain ViroPharma Therapeutics Through Named Patient Program

Older News

EXTON, Pennsylvania and WEYBRIDGE, England, December 6, 2010 - ViroPharma Incorporated (Nasdaq: VPHM) and Idis, the global leader in developing long-term strategic solutions to therapeutic access, today announced that the two companies have partnered to facilitate access to certain ViroPharma products through a named patient program (NPP).

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy